Hikma Pharmaceuticals (HKMPF) News Today $23.70 0.00 (0.00%) (As of 07/26/2024 ET) Add Compare Share Share HeadlinesStock AnalysisAnalyst ForecastsChartDividendHeadlinesShort InterestStock AnalysisAnalyst ForecastsChartDividendHeadlinesShort Interest All Sources Trusted Sources MarketBeat.com Benzinga Bloomberg MarketWatch Motley Fool NASDAQ PR Newswire Reuters Seeking Alpha The Street The Wall Street Journal Yahoo Finance Source Sentiment refers to the positivity or negativity of each headline according to our language processing algorithm. Sentiment All Sentiments Very Positive Positive Neutral Negative Very Negative Most Recent July 2024 June 2024 May 2024 April 2024 March 2024 February 2024 January 2024 December 2023 November 2023 October 2023 September 2023 August 2023 July 2023 June 2023 May 2023 April 2023 March 2023 February 2023 January 2023 December 2022 November 2022 October 2022 September 2022 August 2022 July 2022 June 2022 May 2022 April 2022 March 2022 February 2022 January 2022 December 2021 November 2021 October 2021 September 2021 August 2021 Time Period May 16, 2024 | marketbeat.comHikma Pharmaceuticals PLC (OTCMKTS:HKMPF) Sees Large Growth in Short InterestHikma Pharmaceuticals PLC (OTCMKTS:HKMPF - Get Free Report) saw a large growth in short interest in the month of April. As of April 30th, there was short interest totalling 1,849,700 shares, a growth of 6.2% from the April 15th total of 1,741,900 shares. Based on an average daily trading volume, of 200 shares, the short-interest ratio is presently 9,248.5 days.April 29, 2024 | markets.businessinsider.comCollegium Pharma Partners With Hikma For Authorized Generics Of Nucynta In USMarch 20, 2024 | msn.comHikma Pharmaceuticals PLC goes ex dividend tomorrowMarch 18, 2024 | finance.yahoo.comOptimism around Hikma Pharmaceuticals (LON:HIK) delivering new earnings growth may be shrinking as stock declines 3.3% this past weekFebruary 27, 2024 | finance.yahoo.comHikma Pharmaceuticals PLC (HKMPF)February 22, 2024 | msn.comDrugmaker Hikma expects profit to be slightly lower in 2024February 22, 2024 | markets.businessinsider.comHikma Pharma FY Profit IncreasesFebruary 1, 2024 | msn.comHikma Pharmaceuticals did not report suspicious opioid orders for 15 years, NC Attorney General Josh Stein saysFebruary 1, 2024 | marketwatch.comHikma Pharmaceuticals Agrees in Principle to Pay up to $115M in US Opioid SettlementFebruary 1, 2024 | finance.yahoo.comAd firm Publicis, drugmaker Hikma settle US opioid cases for $500 millionFebruary 1, 2024 | finance.yahoo.comUPDATE 1-Ad firm Publicis, drugmaker Hikma settle US opioid cases for $500 millionJanuary 29, 2024 | finance.yahoo.comHikma Pharmaceuticals PLC's (LON:HIK) Stock Has Seen Strong Momentum: Does That Call For Deeper Study Of Its Financial Prospects?October 5, 2023 | finance.yahoo.comThe one-year decline in earnings might be taking its toll on Hikma Pharmaceuticals (LON:HIK) shareholders as stock falls 3.3% over the past weekOctober 3, 2023 | finance.yahoo.comStocks Open Lower, Weighed Down by Rising Bond YieldsAugust 10, 2023 | finance.yahoo.comRakuten Medical and Hikma Sign Exclusive Licensing Agreement for Alluminox™ Platform Cancer Treatment in the Middle East and North AfricaAugust 9, 2023 | marketwatch.comHikma Appoints Bill Larkins as President of Injectables BusinessJuly 26, 2023 | finance.yahoo.comHikma Ventures invests in Octave Bioscience, a precision care platform for Multiple Sclerosis and other neurodegenerative diseasesMay 6, 2023 | msn.comSelling Hikma Pharmaceuticals After A 40% Share Price Gain In 7 MonthsApril 12, 2023 | lse.co.ukHikma Pharmaceutical appoints Injectables lead Mishlawi as new CEOApril 12, 2023 | nasdaq.comHikma Pharma Appoints Riad Mishlawi As CEO, Effective Sept. 1April 12, 2023 | marketwatch.comHikma Pharmaceuticals Appoints Riad Mishlawi CEOApril 12, 2023 | msn.comHikma Pharma names Mishlawi as next CEOApril 4, 2023 | finance.yahoo.comThose who invested in Hikma Pharmaceuticals (LON:HIK) five years ago are up 57%March 18, 2023 | marketwatch.comHikma Pharmaceuticals rises Thursday, still underperforms marketMarch 15, 2023 | marketwatch.comHikma Pharmaceuticals falls Monday, still outperforms marketMarch 9, 2023 | finance.yahoo.comHikma expands impact in Canada with launches of new sterile injectable medicinesFebruary 27, 2023 | finance.yahoo.comIs Hikma Pharmaceuticals PLC's (LON:HIK) Recent Stock Performance Influenced By Its Fundamentals In Any Way?February 23, 2023 | marketwatch.comHikma Pharmaceutical FY EPS 83.6cFebruary 22, 2023 | finance.yahoo.comHikma accuses Amarin of suppressing generic versions of heart pillDecember 28, 2022 | thestreet.comHikma Pharmaceuticals to Buy Generic Drug Maker Roxane for $2.65 BillionNovember 5, 2022 | benzinga.comHikma Pharmaceuticals Stock (OTC:HKMPF), Earnings Estimates, EPS, and RevenueSeptember 20, 2022 | finance.yahoo.comCould The Market Be Wrong About Hikma Pharmaceuticals PLC (LON:HIK) Given Its Attractive Financial Prospects?September 10, 2022 | seekingalpha.comHKMPF Hikma Pharmaceuticals PLCSeptember 9, 2022 | morningstar.comHikma Pharmaceuticals PLC HKMPF Stock ChartAugust 5, 2022 | seekingalpha.comHikma Pharmaceuticals PLC 2022 Q2 - Results - Earnings Call PresentationAugust 4, 2022 | proactiveinvestors.comHikma Pharma slides on lower generics guidanceAugust 4, 2022 | marketwatch.comHikma Pharmaceuticals Plc 1H Rev $1.21BJune 10, 2022 | finance.yahoo.comHikma Pharmaceuticals PLC (LON:HIK) Shares Could Be 32% Above Their Intrinsic Value EstimateMay 24, 2022 | markets.businessinsider.comHikma Pharma CEO Siggi Olafsson Resigns - Quick FactsMay 5, 2022 | proactiveinvestors.com.auFTSE 100 soars after Wall St 'relief rally' and ahead of Bank of England decision but Hikma dropsApril 29, 2022 | finanznachrichten.deHikma Pharmaceuticals PLC: Hikma confirms that it has not signed a licensing agreement with Opiant PharmaceuticalsApril 29, 2022 | prnewswire.comHikma confirms that it has not signed a licensing agreement with Opiant PharmaceuticalsApril 25, 2022 | marketwatch.comHikma Pharmaceuticals Gets Low Support for Re-Election of Patrick Butler at AGMApril 20, 2022 | proactiveinvestors.com.auFTSE 100 flat but Wall Street makes a positive start despite Netflix flopApril 13, 2022 | finance.yahoo.comCross River Announces Completion of Inaugural Drill Campaign at the McVicar Gold Project, NW OntarioApril 13, 2022 | finance.yahoo.comIs Hikma Pharmaceuticals PLC's (LON:HIK) Stock's Recent Performance A Reflection Of Its Financial Health?March 29, 2022 | finance.yahoo.comHikma Ventures invests in Tact.ai, an AI-powered customer engagement platform for life sciences companiesFebruary 24, 2022 | marketwatch.comHikma Pharmaceutical FY EPS $1.807February 24, 2022 | markets.businessinsider.comHikma Pharma FY21 Profit Down, Lifts Dividend; Stock DownFebruary 24, 2022 | proactiveinvestors.comHikma Pharmaceuticals sales grow 9%, announces US$300mln share buyback Get Hikma Pharmaceuticals News Delivered to You Automatically Sign up to receive the latest news and ratings for HKMPF and its competitors with MarketBeat's FREE daily newsletter. Email Address 625,000% Gain (Ad)Imagine swapping your daily coffee expense for a future free of financial worries. It might seem far-fetched, but results like this are within reach with the right knowledge and timing in the altcoin market. Plus, you’ll get $10 in real Bitcoin when you stay to the end of the call and take a short quiz. >> Dive into the Workshop Here HKMPF Media Mentions By Week HKMPF Media Sentiment Learn about the media sentiment score. Each headline receives a score ranging from 2 (good news) to -2 (bad news). Our company news sentiment scores track the average news sentiment of articles about each company over the most recent 7 days in order to identify companies that are receiving positive press. HKMPF News Sentiment▼-1.300.61▲Average Medical News Sentiment HKMPF News Coverage Learn about the media coverage comparison. We track news headlines from hundreds of news outlets and tag them by company. This chart compares the number of articles about this company in the last seven days compared with the average number of articles about this company on a typical week. HKMPF Articles This Week▼00▲HKMPF Articles Average Week Get Hikma Pharmaceuticals News Delivered to You Automatically Sign up to receive the latest news and ratings for HKMPF and its competitors with MarketBeat's FREE daily newsletter. Email Address Related Companies and Tools Related Companies: Ajinomoto News Commerzbank News CK Hutchison News SGS News Nomura Research Institute News Sandoz Group News Terna News Sands China News China Minsheng Banking News Renault News Headlines Tools: Trending Media MentionsHigh Media Sentiment StocksLive News FeedMarketBeat OriginalsStock Ideas This page (OTCMKTS:HKMPF) was last updated on 7/27/2024 by MarketBeat.com Staff From Our Partners625,000% GainImagine swapping your daily coffee expense for a future free of financial worries. It might seem far-fetche...Crypto Swap Profits | Sponsored“Generational Bull Run” IncomingLIVE Cash Flow Workshop Event / Hosted Virtually Weds @ 7PM EST Everyone who attends will also receive 3 sp...Unstoppable Prosperity | SponsoredNext opportunity for crypto millionsThe Bitcoin halving is the #1 creator of "crypto millionaires". That's because historically, every halving has...Crypto 101 Media | Sponsoredtop AI stock (it’s not MSFT, GOOGL, AMZN or AAPL)AI was by far the biggest tech investing trend right now. But Ross Givens says the #1 artificial intelligen...Traders Agency | SponsoredThe #1 Crypto for 2024 (3 Cent Coin)Chris Rowe – the man who recommended Amazon in 1998… Bitcoin and Ethereum in 2017… And has spotted 44 diffe...True Market Insiders | SponsoredThe #1 Crypto for AIWe’ve issued an urgent landmark trade alert for a new crypto wonder. So, I decided to give you this heads-u...Weiss Ratings | SponsoredDon't Pay a Dime for Marc Lichtenfeld's Top AI PicksUsually, you'd have to plunk down a hefty sum to get your hands on Marc Lichtenfeld's latest income research.....The Oxford Club | SponsoredThe asset beating inflation by 4xCentral Bank Gold Heist In Progress Central banks are buying gold at record rates... and billionaire invest...Colonial Metals | Sponsored Adding Choose a watchlist: Watchlist Adding You have already added five stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding Hikma Pharmaceuticals PLC Please log in to your account or sign up in order to add this asset to your watchlist. Share Hikma Pharmaceuticals With A Colleague Link copied to clipboard. Get 30 Days of MarketBeat All Access for Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools. Start Your 30-Day Trial MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.